Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bio
biology
crispr
jennifer doudna
1963 births
american biochemists
american women scientists
antitrust
berkeley college of chemistry faculty
biological engineering
biotechnology
broad institute
competition
crystallographers
drama
drug patents
editas medicine
emerging technologies
engineering disciplines
enzymes
european commission
generics
genetic engineering
genetics
harvard university alumni
howard hughes medical investigators
living people
members of the national academy of medicine
members of the united states national academy of sciences
molecular biology
non-coding rna
patents
pharma
repetitive dna sequences
tc
university of california
university of california berkeley
women biochemists
yale department of molecular biophysics & biochemistry faculty
What
patent
3
×
rights
3
×
berkeley’s
cas
crispr
doudna
editing
gene
institute
jennifer
read
abused
abusing
actually
amusing
antitrust
argument
arguments
begin
berkeley
broad
california
came
case
charpentier
colleague
commission
company
competition
contender
course
court
created
date
december
decision
delighted
disputed
doudna’s
emmanuelle
Language
unset
Current search:
rights
×
patent
×
@techdirt.com
1 year ago
European Commission Says Pharma Company Teva Abused The Patent System To Violate Antitrust Laws
@techcrunch.com
7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month